Fondo Bibliografico Internacional Julio-Agosto 2006
Miscelánea
Hepatic iron overload associated with a decreased serum ceruloplasmin
level in a novel clinical type of aceruloplasminemia. Ono S, Suzuki H, Takahashi
K, Takahashi Y, Shirakawa K, Murakawa Y, Yamaguchi S, Miyajima H. Gastroenterology
2006;131:240-5.
Aceruloplasminemia y depósito de hierro. Nueva
forma y caso clínico.
Nodular regenerative hyperplasia: not all nodules are created
equal. Reshamwala PA, Kleiner DE, Heller T. Hepatology 2006;44:7-14.
Revisión
Noninvasive markers of fibrosis for longitudinal assessment
of fibrosis in chronic liver disease: are they ready for prime time? Thuluvath
PJ, Krok KL. American Journal of Gastroenterology 2006;101:1497-9.
Editorial
HepatoProteomics: Applying proteomic technologies to the study
of liver function and disease. Diamond DL, Proll SC, Jacobs JM, Chan EY, Camp
DG 2nd, Smith RD, Katze MG. Hepatology 2006;44:299-308.
Revisión.
Pattern recognition receptors: A contemporary view on liver
diseases. Szabo G, Dolganiuc A, Mandrekar P. Hepatology 2006;44:287-98.
Revisión.
Reversibility of hepatic fibrosis in treated genetic hemochromatosis:
A study of 36 cases. Falize L, Guillygomarc'h A, Perrin M, Laine F, Guyader
D, Brissot P, Turlin B,Deugnier Y. Hepatology 2006;44:472-7.
Eficacia de las sangrías para revertir la
fibrosis hepática en los pacientes con hemocromatosis.
Nematode infection of the liver mimicking metastasis of malignant
melanoma. Maier M, Tappe D, Topfer C, Rosenwald A, Gassel HJ, Timm S. Liver
International 2006;26:742-5.
Caso clínico.
Detection of new amino acid markers of liver trauma by proton
nuclear magnetic resonance spectroscopy. Ranjan P, Gupta A, Kumar S, Gowda
GA, Ranjan A, Sonker AA, Chandra A, Ramakant. Liver International 2006;26:703-7.
La determinación de la fenilalanina y de la
tirosina mediante espectrometría por RMN puede ser indicativa de lesión
hepática.
Gender and liver: Is the liver stiffness weaker in weaker sex?
Corpechot C, Naggar AE, Poupon R. Hepatology 2006;44:513-4.
Carta.
Fooling the Fas ligand in death. Rodrigues CM, Steer CJ. Hepatology
2006;44:314-7.
Editorial.
Screening for hemochromatosis: recommendation statement. U.S.
Preventive Services Task Force. Annals of Internal Medicine 2006;145:204-8.
Guía clínica.
Screening for hereditary hemochromatosis: a systematic review
for the U.S. Preventive Services Task Force. Whitlock EP, Garlitz BA, Harris
EL, Beil TL, Smith PR. Annals of Internal Medicine 2006;145:209-23.
Revisión.
Natural history of hepatic sarcoidosis and its response to
treatment. Kennedy PT, Zakaria N, Modawi SB, Papadopoulou AM, Murray-Lyon
I, du Bois RM, Jervoise N Andreyev H, Devlin J. European Journal of Gastroenterology
and Hepatology 2006;18:721-6.
Sarcoidosis como causa de enfermedad hepática
avanzada.
Liver abnormalities in adult celiac disease. Clinicopathologic
characterization and outcome after therapy. Pazo M, Abdulkader I, Otero-Anton
E, Tome S, Villamil I, Gonzalez-Quintela A. Gastroenterologia y Hepatologia
2006;29:383-90.
La dieta libre de gluten normaliza las alteraciones
del perfil hepático en pacientes con enfermedad celiaca.
Different types of liver progenitor cells and their niches.
Roskams T. Journal of Hepatology 2006;45:1-4.
Editorial.
Molecular diagnosis of Alpers syndrome. Nguyen KV, Sharief
FS, Chan SS, Copeland WC, Naviaux RK. Journal of Hepatology 2006;45:108-16.
Diagnostico genético del síndrome de
Alpers, una enfermedad mitocondrial.
Present status and perspectives of cell-based therapies for
liver diseases. Nussler A, Konig S, Ott M, Sokal E, Christ B, Thasler W, Brulport
M, Gabelein G, Schormann W, Schulze M, Ellis E, Kraemer M, Nocken F, Fleig
W, Manns M, Strom SC, Hengstler JG. Journal of Hepatology 2006;45:144-59.
Terapia celular en las enfermedades hepáticas.
Revisión.
Gallbladder disease is associated with insulin resistance in
a high risk Hispanic population. Nervi F, Miquel JF, Alvarez M, Ferreccio
C, Garcia-Zattera MJ, Gonzalez R, Perez-Ayuso RM, Rigotti A, Villarroel L.
Journal of Hepatology 2006;45:299-305.
Resistencia insulínica y colelitiasis.
ER stress: Can the liver cope?. Kaplowitz N. Journal of Hepatology
2006;45:321-33.
Revisión.
The emerging role of bile acids as integrators of intermediary
metabolism. Groen AK. Journal of Hepatology 2006;45:337-8.
Editorial.
Hereditary lysozyme amyloidosis: spontaneous hepatic rupture
(15 years apart) in mother and daughter. Role of emergency liver transplantation.
Loss M, Ng WS, Karim RZ, Strasser SI, Koorey DJ, Gallagher PJ, Verran DJ,
McCaughan GW. Liver Transplantation 2006;12:1152-5.
Caso clínico.
Assessment of portal hemodynamics by Doppler ultrasound and
of liver morphology in the hepatosplenic and hepatointestinal forms of schistosomiasis
mansoni. Vezozzo DC, Farias AQ, Cerri GG, Da Silva LC, Carrilho FJ. Digestive
Diseases and Science 2006;51:1413-9.
Hemodinámica esplácnica en pacientes
con schistosomiasis.
